Back
Can Fite Biofarma Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
31
CANF
Can Fite Biofarma
Last Price:
2.39
Seasonality Move:
2.02%
Buy
94
LBPH
Longboard Pharmaceuticals
Last Price:
34.89
Seasonality Move:
0.54%
Sell
31
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $2.42. The Score for CANF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CANF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
94
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $34.87. The Score for LBPH is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $2.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $34.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
CANF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 43.57 | Sell |
Chaikin Money Flow: | 20090 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.38 - 3.02) | Sell |
Bollinger Bands (100): | (1.98 - 2.6) | Buy |
LBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.22 | Buy |
Relative Strength Index (14 RSI): | 86.65 | Buy |
Chaikin Money Flow: | 484372 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.64 - 26.62) | Buy |
Bollinger Bands (100): | (17.72 - 23.42) | Buy |
CANF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.56 | Sell |
20-day SMA: | 2.76 | Sell |
50-day SMA: | 2.44 | Sell |
200-day SMA: | 2.22 | Buy |
8-day EMA: | 2.55 | Sell |
20-day EMA: | 2.63 | Sell |
50-day EMA: | 2.51 | Sell |
200-day EMA: | 2.51 | Sell |
LBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.37 | Buy |
20-day SMA: | 22.43 | Buy |
50-day SMA: | 21.05 | Buy |
200-day SMA: | 15.33 | Buy |
8-day EMA: | 28.7 | Buy |
20-day EMA: | 24.43 | Buy |
50-day EMA: | 21.77 | Buy |
200-day EMA: | 16.75 | Buy |
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.56 per share, and a decrease next year of $0.55 per share.
Can Fite Biofarma Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Longboard Pharmaceuticals Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |